Nicola Heffron

Fortune : 106 643 $ au 31/05/2024

52 ans

Health Technology

Consumer Services

Postes actifs de Nicola Heffron

Sociétés	Poste	Début	Fin
ALEXION PHARMACEUTICALS, INC.	Sales & Marketing	01/04/2023	-

Sociétés	Poste	Début	Fin
2SEVENTY BIO, INC.	Directeur des opérations	04/11/2021	10/03/2023
CELGENE	Sales & Marketing	01/05/2018	01/09/2018
BLUEBIRD BIO, INC.	Corporate Officer/Principal	01/01/2020	-

University of Warwick

Masters Business Admin

Internationale

Etats-Unis	5
Royaume-Uni	2

Opérationnelle

Sales & Marketing	2
Corporate Officer/Principal	1
Masters Business Admin	1

Sectorielle

Health Technology	5
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
BLUEBIRD BIO, INC.	Health Technology
2SEVENTY BIO, INC.	Health Technology

Entreprise privées	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology

Entreprise privées

Health Technology